The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Innophos Holdings's revenues will increase 6.4% and EPS will drop 0.0%.
The average estimate for revenue is $227.8 million. On the bottom line, the average EPS estimate is $0.81.
Last quarter, Innophos Holdings booked revenue of $214.4 million. GAAP reported sales were 6.1% lower than the prior-year quarter's $228.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.60. GAAP EPS of $0.55 for Q1 were 55% lower than the prior-year quarter's $1.22 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 17.6%, 690 basis points worse than the prior-year quarter. Operating margin was 8.7%, 800 basis points worse than the prior-year quarter. Net margin was 5.8%, 630 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $903.2 million. The average EPS estimate is $3.22.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 784 members out of 807 rating the stock outperform, and 23 members rating it underperform. Among 243 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 238 give Innophos Holdings a green thumbs-up, and five give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Innophos Holdings is outperform, with an average price target of $58.25.
Can your portfolio provide you with enough income to last through retirement? You'll need more than Innophos Holdings. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add Innophos Holdings to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Why NewLink Genetics, Harmonic, and Innophos Holdings Slumped Today
These stocks helped lead the market lower. Find out why.
Why Shares of Innophos Holdings, Inc. Jumped Today
Is this meaningful or just another movement?
5 Stocks Growing Their Dividends by 30% Per Year
If you’d like to boost your dividend income, take a look at these stocks.